User menu

Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Bibliographic reference Sharma, Sharad ; Gurakar, Ahmet ; Jabbour, Nicolas. Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.. In: Digestive Diseases and Sciences, Vol. 53, no.7, p. 1757-1773 (2007)
Permanent URL
  1. Arguedas MR, McGuire BM, Fallon MB, Abrams GA (2001) The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation. Am J Gastroenterol 96(3):833–837
  2. Rabinowitz M, Yoo YK, Schade RR, Dindzans VJ, Van Thiel DH, Gavaler JS (1990) Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci 35:705–710
  3. Weller DA, DeGuide JJ, Riegler JL (1998) Utility of endoscopic evaluations in liver transplant candidates. Am J Gastroenterol 93(8):1346–1350
  4. Zaman A, Hapke R, Flora K, Rosen H, Benner K (1999) Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 94(4):895–899
  5. Grace ND (1992) Prevention of initial variceal hemorrhage. Gastroenterol Clin North Am 21(1):149–161
  6. Grace ND (1997) Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 92:1081–1091
  7. Smith JL, Graham DY (1982) Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 82(5 Pt 1):968–973
  8. de Dombal FT, Clarke JR, Clamp SE, Malizia G, Kotwal MR, Morgan AG (1986) Prognostic factors in upper G.I. bleeding. Endoscopy 18(Suppl 2):6–10
  9. Graham DY, Smith JL (1981) The course of patients after variceal hemorrhage. Gastroenterology 80(4):800–809
  10. D’Amico G, Garcia-Pagan JC, Luca A, Bosch J (2006) Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131(5):1611–1624
  11. Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O (2003) Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 38(3):266–272
  12. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK (1992) Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16(6):1343–1349
  13. Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, Akiyoshi N, Iida T, Yokoyama M, Okumura M (1997) Risk factors for hemorrhage from gastric fundal varices. Hepatology 25(2):307–312
  14. Bosch J, Bordas JM, Rigau J, Viola C, Mastai R, Kravetz D, Navasa M, Rodes J (1986) Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 6(4):667–672
  15. , Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal Varices, 10.1056/nejm198810133191505
  16. Merli M, Nicolini G, Angeloni S et al (2003) Incidence of natural history of small esophageal varices in cirrhotic patients. J Hepatol 38:266
  17. Paquet KJ (1982) Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices—a prospective controlled randomized trial. Endoscopy 14(1):4–5
  18. Witzel L, Wolbergs E, Merki H (1985) Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet 1(8432):773–775
  19. Piai G, Cipolletta L, Claar M, Marone G, Bianco MA, Forte G, Iodice G, Mattera D, Minieri M, Rocco P et al (1988) Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology 8(6):1495–1500
  20. The Veterans Affairs Cooperative Variceal Sclerotherapy Group (1991) Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med 324(25):1779–1784
  21. Van Buuren HR, Rash MC, Bolwerk CJ, Nicolai JJ, Vander Werf SD et al (2003) Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicenter trial. BMC Gastroenterol 3:22
  22. Imperiale TF, Chalasani NA (2001) Meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33(4):802–807
  23. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST (2005) Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 21(4):347–361
  24. Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC (2005) Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 100(4):797–804
  26. Dave P, Romeu J, Messer J (1983) Upper gastrointestinal bleeding in patients with portal hypertension: a reappraisal. J Clin Gastroenterol 5(2):113–115
  27. Sutton FM (1987) Upper gastrointestinal bleeding in patients with esophageal varices. What is the most common source? Am J Med 83(2):273–275
  28. Naparstek Y, Rachmilewitz D (1980) UGI bleeding in a nonalcoholic population with portal hypertension. J Clin Gastroenterol 2(3):239–241
  29. SCHOPPE LESLIE E., ROARK GARY D., PATTERSON MARCEL, Acute Upper Gastrointestinal Bleeding in Patients With Portal Hypertension : A Correlation of Endoscopic Findings With Etiology, 10.1097/00007611-198304000-00015
  30. Buccino RV, Bogliolo G, Ferrara M, Pietropaolo V, Pecchioli L, Miscusi G, Montori A (1990) Endoscopic approach to patients with portal hypertension: a complex diagnosis. A retrospective study based on 10 years’ experience. Surg Endosc 4(2):76–79
  31. Odelowo OO, Smoot DT, Kim K (2002) Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc 94(8):712–715
  32. Prandi D, Rueff B, Roche-Sicot J, Sicot C, Maillard JN, Benhamou JP, Fauvert R (1976) Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt. Am J Surg 131(2):204–209
  33. Mann NS, Hillis A, Mann SK, Buerk CA, Prasad VM (1999) In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease. Hepatogastroenterology 46(25):391–394
  34. Emenike E, Srivastava S, Amoateng-Adjepong Y, Al-Kharrat T, Zarich S, Manthous CA (1999) Myocardial infarction complicating gastrointestinal hemorrhage. Mayo Clin Proc 74(3):235–241
  35. Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodes J (1989) Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology 9(6):808–814
  36. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG (2003) Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9(2):138–143
  37. Chuansumrit A, Chantarojanasiri T, Isarangkura P, Teeraratkul S, Hongeng S, Hathirat P (2000) Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 11(Suppl 1):S101–S105
  38. Negrier C, Lienhart A (2000) Overall experience with NovoSeven. Blood Coagul Fibrinolysis 11(Suppl 1):S19–S24
  39. Kalicinski P, Kaminski A, Drewniak T, Ismail H, Szymczak M, Markiewicz M, Lukasiewicz H (1999) Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 31(1–2):378–379
  40. Thabut D, de Francis R, Bendsten F et al (2003) Efficacy of activated recombinant factor VII (RFVIIA:Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomized placebo-controlled double blind multicenter trial (abstract). J Hepatol 38 (suppl):13
  41. Ejlersen E, Melsen T, Ingerslev J, Andreasen RB, Vilstrup H (2001) Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from esophageal varices. Scand J Gastroenterol 36(10):1081–1085
  42. Bosch J, Thabut D, Bendtsen F, D’Amico G, Albillos A, Gonzalez Abraldes J, Fabricius S, Erhardtsen E, de Franchis R (2004) Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127(4):1123–1130
  43. Soares-Weiser K, Brezis M, Tur-Kaspa R, Paul M, Yahav J, Leibovici L (2003) Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 38(2):193–200
  44. Soriano Germán, Guarner Carlos, Tomás Albert, Villanueva Cándid, Torras Xavier, González Dolors, Sainz Sergio, Anguera Ana, Cussó Xavier, Balanzó Joaquim, Vilardell Francisco, Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage, 10.1016/0016-5085(92)91514-5
  45. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG (1996) Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 24(4):802–806
  46. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T (1998) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis. Digestion 59(Suppl 2):54–57
  47. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J (2002) Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35(1):140–148
  48. Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD (2004) Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39(3):746–753
  49. Fernandez J, Ruiz del Arbol L, Gomez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M (2006) Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131(4):1049–1056; quiz 1285
  50. Knochel JP (1980) Hypophosphatemia in the alcoholic. Arch Intern Med 140(5):613–615
  51. Artz SA, Paes IC, Faloon WW (1966) Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy. Gastroenterology 51(6):1046–1053
  52. Rudolph SJ, Landsverk BK, Freeman ML (2003) Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage. Gastrointest Endosc 57(1):58–61
  53. Waring JP, Sanowski RA, Pardy K, Talbert G, Chinichian A (1991) Does the addition of methylene blue to the sclerosant improve the accuracy of injections during variceal sclerotherapy? Gastrointest Endosc 37(2):159–160
  54. Schuman BM, Beckman JW, Tedesco FJ, Griffin JW Jr, Assad RT (1987) Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 82(9):823–830
  55. Sanowski RA, Waring JP (1987) Endoscopic techniques and complications in variceal sclerotherapy. J Clin Gastroenterol 9(5):504–513
  56. Goulis J, Burroghs A (1999) Portal hypertensive bleeding; prevention and treatment. In: McDonald JBA (ed) Evidence based gastroenterology and hepatology. BMJ Books, London, pp 389–426
  57. Planas R, Quer JC, Boix J, Canet J, Armengol M, Cabre E, Pintanel T, Humbert P, Oller B, Broggi MA et al (1994) A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 20(2):370–375
  58. Sung JJ, Chung SC, Lai CW, Chan FK, Leung JW, Yung MY, Kassianides C, Li AK (1993) Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 342(8872):637–641
  59. Bildozola M, Kravetz D, Argonz J, Romero G, Suarez A, Jmelnitzky A, Fainberg M, Fassio E, Berreta J, Romero G, Landeira G, Martinez H, Bosco A, Guevara M, Valero J, Chopita N, Berenstein G, Terg R (2000) Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand J Gastroenterol 35(4):419–425
  60. D’Amico G, Pietrosi G, Tarantino I, Pagliaro L (2002) Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev (1):CD002233
  61. Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, Salcedo M, Molinero LM (2002) Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35(3):609–615
  62. Stiegmann Greg V., Goff John S., Michaletz-Onody Patrice A., Korula Jacob, Lieberman David, Saeed Zahid A., Reveille R. Matthew, Sun John H., Lowenstein Steven R., Endoscopic Sclerotherapy as Compared with Endoscopic Ligation for Bleeding Esophageal Varices, 10.1056/nejm199206043262304
  63. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, Chiang HT (1997) Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 25(5):1101–1104
  64. Laine Loren, Endoscopic Ligation Compared with Sclerotherapy for the Treatment of Bleeding Esophageal Varices, 10.7326/0003-4819-119-1-199307010-00001
  65. Laine L (1997) Management of actively bleeding esophageal varices. Gastrointest Endosc 46(1):83–84
  66. Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, Leung VK, Li MK, Li AK (1995) Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 346(8991–8992):1666–1669
  67. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D (2001) Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 344(1):23–28
  68. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, de Franchis R, Wagner JL, Conn HO, Rodes J (1998) Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28(3):868–880
  69. Graham DY, Smith JL (1981) The course of patients after variceal hemorrhage. Gastroenterol 80:800–809
  70. Burroughs AK (1993) The natural history of varices. J Hepatol 17(Suppl 2):S10
  71. Sarin SK, Nanda R, Sachdev G, Chari S, Anand BS, Broor SL (1987) Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut 28(6):657–662
  72. Bhargava DK, Singh B, Dogra R, Dasarathy S, Sharma MP (1992) Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents. Am J Gastroenterol 87(2):182–186
  73. Akriviadis E, Korula J, Gupta S, Ko Y, Yamada S (1989) Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules. Dig Dis Sci 34(7):1068–1074
  74. Sarin SK, Sachdev G, Nanda R, Batra SK, Anand BS (1986) Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut 27(6):710–713
  75. Pagliaro L, Burroughs AK, Sorensen TIA et al (1989) Therapeutic controversies and randomized controlled trials: prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Int 2:71
  76. Ferayorni L, Polio J, Groszmann RJ (1996) Drug therapy for portal hypertension: A 5 year review. In: De Francis R (ed) Portal hypertension II: proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Blackwell, Oxford, p 68
  77. D’Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22(1):332–354
  78. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T (1997) Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 26(2):312–324
  79. Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP (2000) Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology 31(6):1239–1245
  80. Lundell L, Leth R, Lind T, Lonroth H, Sjovall M, Olbe L (1990) Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. Acta Chir Scand 156(10):711–715
  81. Jensen LS, Krarup N (1990) Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. Scand J Gastroenterol 25(4):352–356
  82. Bertoni G, Fornaciari G, Beltrami M, Conigliaro R, Grazia Mortilla M, Ricci E, Castagnetti E, Bedogni G, Plancher AC (1990) Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study. J Clin Gastroenterol 12(3):364–365
  83. Avgerinos A, Rekoumis G, Klonis C, Papadimitriou N, Gouma P, Pournaras S, Raptis S (1993) Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol 19(2):301–311
  84. Westaby D, Melia W, Hegarty J, Gimson AE, Stellon AJ, Williams R (1986) Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 6(4):673–675
  85. Vickers C, Rhodes J, Chesner I, Hillenbrand P, Dawson J, Cockel R, Adams D, O’Connor H, Dykes P, Bradby H et al (1994) Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy. J Hepatol 21(1):81–87
  86. Vinel Jean-Pierre, Lamouliatte Herve, Cales Paul, Combis Jean-Marc, Roux Dominique, Desmorat Herve, Pradere Bernard, Barjonnet Georges, Quinton Andre, Pascal Jean-Pierre, Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration, 10.1016/0016-5085(92)91740-u
  87. Acharya SK, Dasarathy S, Saksena S, Pande JN (1993) A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol 19(2):291–300
  88. Gerunda GE, Neri D, Zangrandi F et al (1990) Nadolol does not reduce early rebleeding in cirrhosis undergoing endoscopic variceal sclerotherapy: a multicenter randomized controlled trial. Hepatology 12:988
  89. Laine Loren, Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding : A Meta-Analysis, 10.7326/0003-4819-123-4-199508150-00007
  90. de la Pena J, Rivero M, Sanches F et al (1999) Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage. Prospective randomized trial. Gastrointest Endosc 49(4 Pt 1):417–423
  91. Lo GH, Lai KH, Cheng JS et al (2000) Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: prospective randomized trial. Hepatology 32:461
  92. de la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suarez C (2005) Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41(3):572–578
  93. Heneghan MA, Byrne A, Harrison PM (2002) An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices. Gastrointest Endosc 56(3):422–426
  94. Sarin SK, Lahoti D (1992) Management of gastric varices. Baillieres Clin Gastroenterol 6(3):527–548
  95. Trudeau W, Prindiville T (1986) Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 32(4):264–268
  96. Sarin SK (1997) Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 46(1):8–14
  97. Gimson AE, Westaby D, Williams R (1991) Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 13(3):274–278
  98. Dhiman RK, Chawla Y, Taneja S, Biswas R, Sharma TR, Dilawari JB (2002) Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol 35(3):222–227
  99. Greenwald BD, Caldwell SH, Hespenheide EE, Patrie JT, Williams J, Binmoeller KF, Woodall L, Haluszka O (2003) N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol 98(9):1982–1988
  100. Iwase H, Maeda O, Shimada M, Tsuzuki T, Peek RM Jr, Nishio Y, Ando T, Ina K, Kusugami K (2001) Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastrointest Endosc 53(6):585–592
  101. Kind R, Guglielmi A, Rodella L, Lombardo F, Catalano F, Ruzzenente A, Borzellino G, Girlanda R, Leopardi F, Prattico F, Cordiano C (2000) Bucrylate treatment of bleeding gastric varices: 12 years’ experience. Endoscopy 32(7):512–519
  102. Ramond MJ, Valla D, Mosnier JF, Degott C, Bernuau J, Rueff B, Benhamou JP (1989) Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology 10(4):488–493
  103. Sheikh RA, Trudeau WL (2000) Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding. Gastrointest Endosc 52(1):142–144
  104. Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K (1995) Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 27(5):349–354
  105. Ogawa K, Ishikawa S, Naritaka Y, Shimakawa T, Wagatsuma Y, Katsube A, Kajiwara T (1999) Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol 14(3):245–250
  106. Sarin SK, Jain AK, Jain M, Gupta R (2002) A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 97(4):1010–1015
  107. Roesch W, Rexroth G (1998) Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 30(8):S89–S90
  108. Hwang SS, Kim HH, Park SH, Kim SE, Jung JI, Ahn BY, Kim SH, Chung SK, Park YH, Choi KH (2001) N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr 25(1):16–22
  109. Palejwala AA, Smart HL, Hughes M (2000) Multiple pulmonary glue emboli following gastric variceal obliteration. Endoscopy 32:S1–S2
  110. Yu LK, Hsu CW, Tseng JH, Liu NJ, Sheen IS (2005) Splenic infarction complicated by splenic artery occlusion after N-butyl-2-cyanoacrylate injection for gastric varices: case report. Gastrointest Endosc 61:343–345
  111. Williams SG, Peters RA, Westaby D (1994) Thrombin—an effective treatment for gastric variceal haemorrhage. Gut 35(9):1287–1289
  112. Przemioslo RT, McNair A, Williams R (1999) Thrombin is effective in arresting bleeding from gastric variceal hemorrhage. Dig Dis Sci 44(4):778–781
  113. Yang WL, Tripathi D, Therapondos G, Todd A, Hayes PC (2002) Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol 97(6):1381–1385
  114. Kitano S, Hashizume M, Yamaga H, Wada H, Iso Y, Iwanaga T, Sugimachi K (1989) Human thrombin plus 5 percent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial. Br J Surg 76(7):715–718
  115. Snobl J, Van Buuren HR, Van Blankenstein M (1992) Endoscopic injection using thrombin: an effective and safe method for controlling oesophagogastric variceal bleeding. Gastroenterology 102:A891 (abstract)
  116. Datta D, Vlavianos P, Alisa A, Westaby D (2003) Use of fibrin glue (beriplast) in the management of bleeding gastric varices. Endoscopy 35(8):675–678
  117. Arakaki Y, Murakami K, Takahashi K, Sato R, Okimoto T, Ishitobi H, Nasu M, Kagawa J, Kodama M, Fujioka T (2003) Clinical evaluation of combined endoscopic variceal ligation and sclerotherapy of gastric varices in liver cirrhosis. Endoscopy 35(11):940–945
  118. Tan PC, Hou MC, Lin HC, Liu TT, Lee FY, Chang FY, Lee SD (2006) A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 43(4):690–697
  119. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT (2001) A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33(5):1060–1064
  120. Jalan R, Hayes PC (2000) UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterol. Gut 46(Suppl 3–4):III1–III15
  121. Battaglia G, Bocus P, Morbin T, Ancona E (2003) Endoscopic Doppler US-guided injection therapy for gastric varices: case report. Gastrointest Endosc 57(4):608–611
  122. Lee YT, Chan FK, Ng EK, Leung VK, Law KB, Yung MY, Chung SC, Sung JJ (2000) EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc 52(2):168–174
  123. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA (1984) Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 87(5):1165–1170
  124. Gretz JE, Achem SR (1998) The watermelon stomach: clinical presentation, diagnosis, and treatment. Am J Gastroenterol 93(6):890–895
  125. Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R (1992) The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 15(3):256–263
  126. Calamia KT, Scolapio JS, Viggiano TR (2000) Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin Exp Rheumatol 18(5):605–608
  127. Ward EM, Raimondo M, Rosser BG, Wallace BG, Dickson RD (2004) Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol 38(10):898–900
  128. Egger C, Kreczy A, Kirchmair R, Waldenberger P, Jaschke W, Vogel W (1997) Gastric antral vascular ectasia with portal hypertension: treatment with TIPSS. Am J Gastroenterol 92(12):2292–2294
  129. Vincent C, Pomier-Layrargues G, Dagenais M, Lapointe R, Letourneau R, Roy A, Pare P, Huet PM (2002) Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transpl 8(8):717–720
  130. Iwao Tadashi, Toyonaga Atsushi, Sumino Michihiro, Takagi Kohsuke, Oho Kazuhiko, Nishizono Masatoshi, Ohkubo Kazunori, Inoue Rintaroh, Sasaki Ei, Tanikawa Kyuichi, Portal hypertensive gastropathy in patients with cirrhosis, 10.1016/0016-5085(92)90332-s
  131. Fontana RJ, Sanyal AJ, Mehta S, Doherty MC, Neuschwander-Tetri BA, Everson GT, Kahn JA, Malet PF, Sheikh MY, Chung RT, Ghany MG, Gretch DR (2006) Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol 101(5):983–992
  132. Trevino HH, Brady CE 3rd, Schenker S (1996) Portal hypertensive gastropathy. Dig Dis Sci 14(4):258–270
  133. Ohta M, Hashizume M, Higashi H, Ueno K, Tomikawa M, Kishihara F, Kawanaka H, Tanoue K, Sugimachi K (1994) Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 20(6):1432–1436
  134. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, De Franchis R (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119(1):181–187
  135. Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, Rigau J, Quintero E, Valderrama R, Viver J et al (1991) Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337(8755):1431–1434
  136. Orloff MJ, Orloff MS, Orloff SL, Rambotti M, Girard B (1995) Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 180(3):257–272
  137. Lafortune M, Martinet J P, Denys A, Patriquin H, Dauzat M, Dufresne M P, Colombato L, Pomier-Layrargues G, Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study., 10.2214/ajr.164.4.7726065
  138. Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC (1996) Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut 39(3):479–485
  139. DeWeert TM, Gostout CJ, Wiesner RH (1990) Congestive gastropathy and other upper endoscopic findings in 81 consecutive patients undergoing orthotopic liver transplantation. Am J Gastroenterol 85(5):573–576
  140. Siringo S, Burroughs AK, Bolondi L, Muia A, Di Febo G, Miglioli M, Cavalli G, Barbara L (1995) Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 22(6):633–641
  141. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD (1996) Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 11(1):59–64
  142. Tsai CJ (1998) Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 43(6):1219–1225
  143. Kachintorn U, Luengrojanakul P, Atisook K, Theerabutra C, Tanwandee T, Boonyapisit S, Chinapak O (1992) Helicobacter pylori and peptic ulcer diseases: prevalence and association with antral gastritis in 210 patients. J Med Assoc Thai 75(7):386–392
  144. Auroux J, Lamarque D, Roudot-Thoraval F, Deforges L, Chaumette MT, Richardet JP, Delchier JC (2003) Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci 48(6):1118–1123
  145. Kuipers EJ, Thijs JC, Festen HP (1995) The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 9(Suppl 2):59–69
  146. Wu CS, Lin CY, Liaw YF (1995) Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 42(5):424–427
  147. Schmulson MJ, De Leon G, Kershenovich A, Vargas-Vorackova F, Kershenobich D (1997) Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis. Helicobacter 2(3):149–151
  148. Bahnacy A, Kupcsulik P, Eles Z, Jaray B, Flautner L (1996) Helicobacter pylori infection in congestive gastropathy. Helicobacter 1(3):168–171
  149. Eastwood GL (1997) Is smoking still important in the pathogenesis of peptic ulcer disease? J Clin Gastroenterol 25(Suppl 1):S1–S7
  150. Chow JY, Ma L, Zhu M, Cho CH (1997) The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats. Gastroenterology 113(4):1188–1197
  151. Friedman Gary D., Siegelaub A. B., Seltzer Carl C., Cigarettes, Alcohol, Coffee and Peptic Ulcer, 10.1056/nejm197402282900901
  152. Iwao T, Toyonaga A, Ikegami M, Shigemori H, Oho K, Sumino M, Tanikawa K (1996) Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone. Dig Dis Sci 41(9):1727–1732
  153. Sarfeh IJ, Soliman H, Waxman K et al (1989) Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci 34:225–228
  154. Guslandi M, Sorghi M, Foppa L, Tittobello A (1992) Assessment of mucosal defenses in portal hypertensive gastropathy. J Hepatol 16(1–2):248
  155. Di Mario F, Gottardello L, Germana B, Dotto P, Grassi SA, Vianello F, Battaglia G, Leandro G, Burra P, Salvagnini M et al (1992) Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol 24(3):122–125
  156. Yeh JL, Peng YC, Tung CF, Chen GH, Chow WK, Chang CS, Yeh HZ, Poon SK (2001) Role of Helicobacter pylori in cirrhotic patients with dyspepsia: a 13C-urea breath test study. Adv Ther 18(3):140–150
  157. Akatsu T, Yoshida M, Kawachi S, Tanabe M, Shimazu M, Kumai K, Kitajima M (2006) Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis. Dig Dis Sci 51(11):2018–2022
  158. Lo GH, Yu HC, Chan YC, Chen WC, Hsu PI, Lin CK, Lai KH (2005) The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 62(3):350–356
  159. Penn I (1993) The effect of immunosuppression on pre-existing cancers. Transplantation 55(4):742–747
  160. Kozarek R.A., Botoman V.A., Bredfeldt J.E., Roach J.M., Patterson D.J., Ball T.J., Portal colopathy: Prospective study of colonoscopy in patients with portal hypertension, 10.1016/0016-5085(91)90067-u
  161. Naveau S, Bedossa P, Poynard T, Mory B, Chaput JC (1991) Portal hypertensive colopathy. A new entity. Dig Dis Sci 36(12):1774–1781
  162. Weinshel Elizabeth, Chen William, Falkenstein David B., Kessler Richard, Raicht Robert F., Hemorrhoids or Rectal Varices: Defining the Cause of Massive Rectal Hemorrhage in Patients With Portal Hypertension, 10.1016/0016-5085(86)91132-7
  163. Tam TN, Ng WW, Lee SD (1995) Colonic mucosal changes in patients with liver cirrhosis. Gastrointest Endosc 42(5):408–412
  164. Bini EJ, Lascarides CE, Micale PL, Weinshel EH (2000) Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study. Gastrointest Endosc 52(4):511–516
  165. Ito Keiichi, Portal hypertensive colopathy in patients with liver cirrhosis, 10.3748/wjg.v11.i20.3127
  166. Misra SP, Dwivedi M, Misra V (1996) Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension. Endoscopy 28(4):340–345
  167. Bresci G, Gambardella L, Parisi G, Federici G, Bertini M, Rindi G, Metrangolo S, Tumino E, Bertoni M, Cagno MC, Capria A (1998) Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol 26(3):222–227
  168. Yamakado S, Kanazawa H, Kobayashi M (1995) Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure. Intern Med 34(3):153–157
  169. Viggiano TR, Gostout CJ (1992) Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features. Am J Gastroenterol 87(8):944–954
  170. Misra SP, Dwivedi M, Misra V (1996) Prevalence and factors influencing hemorrhoids, anorectal varices and colopathy in patients with portal hypertension. Endoscopy 28(4):340–345
  171. Waxman JS, Tarkin N, Dave P, Waxman M (1984) Fatal hemorrhage from rectal varices. Report of two cases. Dis Colon Rectum 27(11):749–750
  172. Ponce Gonzalez JF, Dominguez Adame Lanuza E, Martin Zurita I, Morales Mendez S (1998) Portal hypertensive colopathy: histologic appearance of the colonic mucosa. Hepatogastroenterology 45(19):40–43
  173. Hosking SW, Kennedy HJ, Seddon I, Triger DR (1987) The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 7(3):437–441
  174. Balzer C, Lotterer E, Kleber G, Fleig WE (1998) Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy. Gastroenterology 115(1):167–172
  175. Hamlyn AN, Morris JS, Lunzer MR, Puritz H, Dick R (1974) Portal hypertension with varices in unusual sites. Lancet 2(7896):1531–1534
  176. Hosking SW, Smart HL, Johnson AG, Triger DR (1989) Anorectal varices, haemorrhoids, and portal hypertension. Lancet 1(8634):349–352
  177. Ganguly S, Sarin SK, Bhatia V, Lahoti D (1995) The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 21(5):1226–1231
  178. Goenka MK, Kochhar R, Nagi B, Mehta SK (1991) Rectosigmoid varices and other mucosal changes in patients with portal hypertension. Am J Gastroenterol 86(9):1185–1189
  179. Herman BE, Baum S, Denobile J, Volpe RJ (1993) Massive bleeding from rectal varices. Am J Gastroenterol 88(6):939–942
  180. Weiserbs DB, Zfass AM, Messmer J (1986) Control of massive hemorrhage from rectal varices with sclerotherapy. Gastrointest Endosc 32(6):419–421
  181. Longo A (1998) Treatment of hemorrhoidal disease by reduction of mucosa and hemorrhoidal prolapse with a circular suturing device: a new procedure. In: Proceedings of the 6th world congress of endoscopic surgery. Rome, Italy, June 3–6
  182. Huang WS (2007) Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience. Int J Colorectal Dis 22(9):1083–1089
  183. Naveau S, Chaput JC, Bedossa P, Poynard T, Pauphilet C, Ink O, Houdayer C, Aubert A (1992) Cirrhosis as an independent risk factor for colonic adenomas. Gut 33(4):535–540
  184. Bardou M, Montembault S, Giraud V, Balian A, Borotto E, Houdayer C, Capron F, Chaput JC, Naveau S (2002) Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study. Gut 50(1):38–42
  185. Ghalib R, Zuckerman G, Lowell T et al (1995) The value of lower GI studies for patients undergoing liver transplantation evaluation. Gastroenterology 108:1071
  186. Ransohoff David F., Colon cancer in ulcerative colitis, 10.1016/0016-5085(88)90573-2
  187. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin CE (1996) Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110(2):331–338
  188. Mammen Eberhard F., Coagulation defects in liver disease, 10.1016/s0025-7125(16)30146-8
  189. Bernstein DE, Jeffers L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, Bech R, Hedner U, Schiff ER (1997) Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 113(6):1930–1937
  190. Bernstein D (2000) Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child’s B and C cirrhosis. Semin Thromb Hemost 26(4):437–438